MedTrace Logo

Progressive Muscle Relaxation for Pain and Quality of Life in Thyroid Cancer

NCT07623005 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2026-06-03

No results posted yet for this study

Summary

Thyroid cancer patients often experience pain and reduced quality of life during chemotherapy. This randomized controlled trial will evaluate whether Progressive Muscle Relaxation (PMR) exercises, added to routine range-of-motion exercises, reduce pain and improve quality of life compared to range-of-motion exercises alone. Thirty-two thyroid cancer patients randomly assigned to either the PMR group or the control group. Pain measured by using the Numeric Pain Rating Scale (NPRS) and quality of life using the FACT-G questionnaire before and after a 4-5 day intervention. The study compared changes between groups.

Conditions

Interventions

BEHAVIORAL

Progressive Muscle Relaxation Technique

Participants were guided through sequential tensing and relaxing of six muscle groups: head/neck, shoulders/upper back, arms/hands, lower back/hips, calves/thighs, and feet/toes. For each group, they inhaled deeply and tensed muscles for 10-20 seconds, then exhaled slowly while relaxing completely. Each session lasted 20-40 minutes, once daily for 4-5 consecutive days. Sessions were conducted by a trained physiotherapist in a quiet hospital room.

OTHER

Range of Motion and Stretching Exercises

Participants performed gentle range-of-motion (ROM) and stretching exercises for the same muscle groups (head/neck, shoulders, arms, lower back, legs, feet), without the tensing-relaxation component of PMR. Each session lasted 20-40 minutes, once daily for 4-5 consecutive days, supervised by the same physiotherapist.

Sponsors & Collaborators

  • University of Faisalabad

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-01
Primary Completion
2026-04-01
Completion
2026-05-15

Countries

  • Pakistan

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07623005 on ClinicalTrials.gov